Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 17

1.

Clinical features associated with costs in early AD: baseline data from the Predictors Study.

Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

Neurology. 2006 Apr 11;66(7):1021-8.

PMID:
16606913
2.

The pharmacoeconomics of Alzheimer's disease.

Fillit HM.

Am J Manag Care. 2000 Dec;6(22 Suppl):S1139-44; discussion S1145-8. Review.

3.

Economic considerations in Alzheimer's disease.

Meek PD, McKeithan K, Schumock GT.

Pharmacotherapy. 1998 Mar-Apr;18(2 Pt 2):68-73; discussion 79-82. Review.

PMID:
9543467
5.

The economic impact of neuropsychiatric symptoms in Alzheimer's disease: can drugs ease the burden?

Murman DL, Colenda CC.

Pharmacoeconomics. 2005;23(3):227-42. Review.

PMID:
15836005
6.

A review of the methods used to estimate the cost of Alzheimer's disease in the United States.

Mauskopf J, Mucha L.

Am J Alzheimers Dis Other Demen. 2011 Jun;26(4):298-309. doi: 10.1177/1533317511407481. Epub 2011 May 11. Review.

PMID:
21561991
7.

The burden of schizophrenia on caregivers: a review.

Awad AG, Voruganti LN.

Pharmacoeconomics. 2008;26(2):149-62. Review.

PMID:
18198934
8.

The cost of dementia in Europe: a review of the evidence, and methodological considerations.

J├Ânsson L, Wimo A.

Pharmacoeconomics. 2009;27(5):391-403. doi: 10.2165/00019053-200927050-00004. Review.

PMID:
19586077
9.

The costs of caring: medical costs of Alzheimer's disease and the managed care environment.

Murman DL.

J Geriatr Psychiatry Neurol. 2001 Winter;14(4):168-78. Review.

PMID:
11794445
10.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

12.

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.

PMID:
17669232
13.
14.

A systematic review of low back pain cost of illness studies in the United States and internationally.

Dagenais S, Caro J, Haldeman S.

Spine J. 2008 Jan-Feb;8(1):8-20. doi: 10.1016/j.spinee.2007.10.005. Review.

PMID:
18164449
15.

Costs of dementia and dementia care: a review.

Wimo A, Ljunggren G, Winblad B.

Int J Geriatr Psychiatry. 1997 Aug;12(8):841-56. Review.

PMID:
9283930
16.

The increasing burden of Alzheimer disease.

Sadik K, Wilcock G.

Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17 Suppl 3:S75-9. Review.

PMID:
14512820
17.

Alzheimer's disease costs: what we know and what we should take into account.

Colucci L, Bosco M, Fasanaro AM, Gaeta GL, Ricci G, Amenta F.

J Alzheimers Dis. 2014;42(4):1311-24. doi: 10.3233/JAD-131556. Review.

PMID:
25024334
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk